ÂÜÀòÂÒÂ×

Thomas Linz is an accomplished scientist with extensive experience in biotherapeutics and analytical chemistry. Currently serving as a Senior Scientist II at Catalent Pharma Solutions, Thomas specializes in the characterization of monoclonal antibodies and antibody-drug conjugates, along with the design and management of pharmacokinetic and toxicokinetic preclinical studies. Previous roles include Associate Scientist at 4D Molecular Therapeutics and Research Associate at Catalent, where Thomas focused on bioanalytical method development and protein characterization techniques. Thomas's background also includes significant contributions during a Graduate Research Fellowship at Rutgers University, where novel targeted liposomal treatments for cancer were developed, as well as prior experience in process R&D and analytical chemistry. Thomas holds a Master’s Degree in Chemical and Biomedical Engineering from Rutgers University and a Bachelor of Science in Chemistry from the University of Oregon.